In MS-like mice, blocking vessel growth did not help

Credibility

Interest

Share:1 min read

Key Takeaway

Blocking a signal that grows new blood vessels reduced vessel growth in mice with an MS-like disease, but did not improve the disease.

What They Found

In mice with an MS-like disease, cells lining veins multiplied in areas of nerve-covering damage. The veins grew larger and covered more of those areas. The researchers also found signs of new blood vessel growth in donated tissue from people with MS. Blocking a signal involved in vessel growth reduced this growth in the mice. It did not repair the barrier that protects the brain or improve the mice's disease.

Who Should Care and Why

This study examined adult female mice with an MS-like disease and donated tissue from people with MS. The mouse findings came from areas with recent and long-lasting nerve-covering damage. The human tissue also showed signs of new blood vessel growth in damaged areas. People interested in how blood vessels change in MS may find these results relevant. The treatment result applies to the mice, not to people with MS.

Important Considerations

You should know the treatment was tested in mice, not in people. The abstract does not state how many mice were studied or how many people donated tissue. These findings do not show whether blocking the same signal would affect MS in people.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Early Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Nature neuroscience often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News